Studies from University of Tennessee Health Science Center in the Area of Prostate Cancer Described (Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer)

Source :: Obesity, Fitness & Wellness Week. November 14, 2020, 7216
Publication Year :: 2020
Abstract: 2020 NOV 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Prostate Cancer. According to news [...]

Subjects :: Physical fitness -- Chemical properties -- Research
Enzalutamide -- Research
Cancer research -- Chemical properties
Prostate cancer -- Research -- Care and treatment
Health

Tools